Patient Recruitment

Envision Pharma Group announces the successful implementation of iEnvision to connect and support Otsuka’s medical affairs activities

May 15, 2018

Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) has completed the first phase of implementation of the iEnvision medical affairs platform developed by Envision Technology Solutions, part of Envision Pharma Group. iEnvision is a web-based software platform specifically designed and developed to support multiple medical affairs-related programs of activity. Otsuka is deploying iEnvision to manage several […]

CRF Health’s TrialMax eCOA Solution Selected for Landmark Pain Outcomes Study by Global Japanese Pharmaceutical Company

April 23, 2018

Plymouth Meeting, PA – April 23, 2018: CRF Health, the leading provider of patient-centered eSource for the life sciences industry, today announced that its TrialMax Touch® and TrialMax Slate® solutions have been selected by a Global Category Japanese Pharmaceutical company for a significant pain trial. The Phase III trial will involve 800 screened and 320 […]

Ten Tips for Writing Compliant Participant Materials

March 22, 2018

Recruitment materials are the first introduction to a study for potential participants, and post-consent materials can influence decisions about continued participation. It is important to adhere to the principles of subject protection—that is, allowing subjects to make informed decisions about what is in their own best interest— with the materials that appear at the earliest stages of recruitment and through the […]

Wout Brusselaers to Speak at HIMSS18 on Finding the Return on Investment of Artificial Intelligence

February 14, 2018

HIMSS has named Wout Brusselaers, chief executive officer of Deep 6 AI , an artificial intelligence (AI) company focused on accelerating patient recruitment for clinical trials, as a speaker for the 2018 HIMSS Conference & Exhibition (HIMSS18). Brusselaers will co-present the “Finding the ROI of AI” educational session with Bobbie J. Rimel, MD, gynecologic oncologist and associate director for gynecological […]

FEEDBACK